טוען...

Ten-Year Real-World Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration

BACKGROUND: Neovascular age-related macular degeneration (nAMD) has been treated with anti-vascular endothelial growth factor (anti-VEGF) therapy since 2006 with initial efficacy evidence of 2 years. In many, long-term therapy is required, and evidence for benefit is required from real-world data co...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Clin Ophthalmol
Main Authors: Cheema, Muhammad Raza, DaCosta, Joanna, Talks, James
פורמט: Artigo
שפה:Inglês
יצא לאור: Dove 2021
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7837532/
https://ncbi.nlm.nih.gov/pubmed/33519189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S269162
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!